AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

969.465

-3.444-0.35%

Number of Gainers:2

Number of Losers:12

Number of Flat:19

PE:- -

High:979.351

Open:979.351

Low:968.651

Close:972.910

Volume:6.30M

Turnover:83.26M

Market Cap:240.20B

Float Cap:195.94B

Loading ...

Asia Morning Call-Global Markets

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven

Simply Wall St.

Commonwealth Bank of Australia Expands Loyalty Program, Partners With Multiple Brands

MT Newswires Live

Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook

CSL's Fiscal 2026 Results In Line, Jefferies Says

MT Newswires Live

Australia's CSL Eyes Best Day in 25 Years on Strong FY Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK7501/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":969.4652,"timestamp":1788312523302,"preClose":972.90955,"halted":0,"volume":6300741,"delay":0,"changeRate":-0.00354,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-3.444336,"latestTime":"09-02 11:28:45 AEST","open":979.3509,"high":979.3509,"low":968.6505,"amount":83256382,"amplitude":0.010998,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788328800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788307200000,1788328800000]],"turnoverRate":0.000455,"increases":3,"decrements":13,"flats":15,"marketCap":240203198423.25,"floatMarketCap":195935298567.8047},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":979.3509,"amplitude":0.010998,"preClose":972.90955,"low":968.6505,"latestPrice":969.4652,"volume":6300741,"delay":0,"open":979.3509,"prevYearClose":900.1661,"prevWeekClose":972.495,"prevMonthClose":977.169,"prevQuarterClose":826.677,"fiveDayClose":983.174,"twentyDayClose":873.223,"sixtyDayClose":777.222,"secType":"PLATE","market":"AU","turnoverRate":0.000455,"marketCap":240203198423.25,"floatMarketCap":195935298567.8047,"timestamp":1788312523302,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":2,"down":12,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660916144","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2660916144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660916144?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:39","pubTimestamp":1787078393,"startTime":"0","endTime":"0","summary":"Asia Morning Call-Global MarketsAug 19 (Reuters)-Stock MarketsNet ChngStock MarketsNet ChngS&P/ASX 200**9070.00-3.20NZX 50**13866.18144.20DJIA53377.48-82.30NIKKEI**67460.73-1,759.52Nasdaq26316.48-327.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK7501","LU1267930730.SGD","CSL.AU","FDIQ","LU1691799644.USD","BK4588","LU0390134368.USD","LU0109391861.USD","LU2095319765.USD","LU0672654240.SGD","LU2265009873.SGD","LU0175139822.USD","LU0708995401.HKD","BK4112","LU0289960550.SGD","BK4585","LU2210149790.SGD","LU2210150020.SGD","BK7508","BK7067","MSCI","LU1804176565.USD","LU0289961442.SGD","LU0511384066.AUD","LU0320765059.SGD","BK7511","LU0289739343.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466734","title":"Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466734?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047565,"startTime":"0","endTime":"0","summary":"Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposablesHaemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026 for N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLpVv5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CSL.AU","BK7501","LU1169589451.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","BK7508","LU0205194284.USD","HAE","IE0034390439.USD","IE00B19Z6F94.USD","LU0106261612.USD","LU0205193047.USD","LU1169590202.USD","BK7511","LU0012050646.USD","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466219","title":"CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466219?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:22","pubTimestamp":1787044958,"startTime":"0","endTime":"0","summary":"CSL stock went into this result having climbed over the past quarter, closing at A$157.82, yet the latest numbers land with a jolt. The global biotech giant posted a trailing twelve month loss from continuing operations of US$2.99b on revenue of US$15.80b. That kind of earnings squeeze grabs short term traders by the throat. For long term investors, the real question now is how to weigh that loss against analyst forecasts that point to a return to profitability, as well as the current gap...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FEBU","BK7501","CSL.AU","JOYT","VOTE","DECU","LU0728928796.USD","RGLO","BK7511","BK4086","VGFPF","SG9999004303.SGD","SGXZ23171101.USD","GXDW","CSL","BK7067","LU1169590202.USD","PMDE","BK7508","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660638452","title":"Commonwealth Bank of Australia Expands Loyalty Program, Partners With Multiple Brands","url":"https://stock-news.laohu8.com/highlight/detail?id=2660638452","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660638452?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:21","pubTimestamp":1787034110,"startTime":"0","endTime":"0","summary":"Commonwealth Bank of Australia  said a new change to its CommBank Yello loyalty program will make more than nine million customers eligible to earn points on home loans, savings accounts, insurance and credit cards, according to a Tuesday statement.The bank said eligible customers will be able to earn, track and redeem points within the CommBank app and NetBank, with points redeemable on everyday essentials such as groceries, utility bills and fuel as well as dining and travel, working with established brands including Woolworths'  Everyday Rewards, Origin Energy , Myer , and Velocity Frequent Flyer.Virgin Australia  said the partnership between its Velocity Frequent Flyer loyalty program and CBA's Yello program will allow customers to earn Velocity Points on consumer banking products.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7507","ORG.AU","BK7135","VAP.AU","SLF.AU","CBA.AU","BK7130","BK7153","BBOZ.AU","IOZ.AU","BK7501","BK7511","DACE.AU","GIVE.AU","QFN.AU","BK7006","BK7029","QRE.AU","STW.AU","BK7040","EIGA.AU","OZF.AU","VAS.AU","WOW.AU","IISV.AU","XJO.AU","E200.AU","OZR.AU","IMLC.AU","IIGF.AU","BK7021","XAO.AU","BEAR.AU","XKO.AU","GEAR.AU","MYR.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454593","title":"Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454593?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:26","pubTimestamp":1787030795,"startTime":"0","endTime":"0","summary":"Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlookOverviewSwitzerland biopharma firm's H1 2026 revenue grew 14% yr/yr to CHF 119 mlnOperating profit for H1 2026 rose 32","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","002422","BK1161","BK0060","LU1064131003.USD","BK7508","LU2148510915.USD","00656","02696","HK0000165453.HKD","HK0000320223.HKD","LU1979443071.USD","BK0239","BK7511","06990","HK0000306685.HKD","BK7067","BK7501","LU1934453819.USD","CSL.AU","LU0196878994.USD","BK1230","HK0000306701.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660745574","title":"CSL's Fiscal 2026 Results In Line, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660745574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660745574?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:00","pubTimestamp":1787018443,"startTime":"0","endTime":"0","summary":"CSL's  fiscal 2026 results are in line, and it guided for fiscal 2027 net profit after tax  growth of around 5%, Jefferies said in a Tuesday note.The firm's normalized fiscal 2026 net profit after tax and before amortization of $3.1 billion fell around 4% year-over-year and 2% in constant currency, compared with the brokerage's forecast of $3.09 billion.Its fiscal 2026 normalized earnings per share of $5.38 decreased around 3% on the year-ago period, compared with Jefferies' estimate of $5.76.Its fiscal 2027 revenue is expected by the firm to be in line with the prior year and underlying NPAT growth of around 5%, implying an underlying CSL fiscal 2027 NPAT of around $2.98 billion on a constant currency basis, compared with Jefferies' forecast of $2.8 billion on a non-constant currency basis.The investment firm assigned CSL a hold rating and a price target of AU$119 per share.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7511","SG9999004303.SGD","SGXZ23171101.USD","CSL.AU","BK4086","BK7067","CSL","LU0728928796.USD","LU1169589451.USD","BK7508","LU1169590202.USD","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453002","title":"Australia's CSL Eyes Best Day in 25 Years on Strong FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453002","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453002?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:20","pubTimestamp":1787016055,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL eyes best day in 25 years on strong FY outlook** Shares of CSLCSL.AXrise as much as 18.1% to A$159.01, hitting their highest level since February 12** Stock set for best intraday trading session since June 2001** Biotech giant reportsbetter-than-expectedfull-year underlying earnings and forecasts strong growth in 2027 on the back of its core plasma division** CSL posts underlying NPAT attributable of $3.14 bln on a constant currency basis, topping Visible Alpha consensus estimate of $3.08 bln** Plasma therapies unit CSL Behring expected to post mid-single-digit revenue growth in FY 2027** Co unveils A$1.1 bln  share buyback programme** With much of the earnings damage already reflected in a share price near multi-year lows, the buyback and a more constructive outlook for Behring are strengthening view that the worst may be behind CSL - Hebe Chen, market analyst at Vantage Markets** Day's moves cut stock's YTD losses to 9.2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F01G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0342679015.USD","LU1989764664.SGD","LU2506952097.USD","LU0097036916.USD","SG9999017495.SGD","FDIQ","LU0175139822.USD","LU1363072403.SGD","BK7501","LU1989772923.USD","LU0354030438.USD","LU1496350502.SGD","LU0823417737.USD","LU1989763005.USD","LU2720916845.USD","LU0094547139.USD","LU1804176565.USD","CSL.AU","LU2506952170.USD","SGXZ31699556.SGD","LU0158827948.USD","LU2095319765.USD","BK4581","BK7067","LU0154236417.USD","BK4548","LU2210150020.SGD","BK4534","LU2265009873.SGD","BK4585","LU2271345857.HKD","LU2089283258.USD","LU1989773731.SGD","BK4566","LU1988902786.USD","LU2506951875.HKD","SPGI","SG9999001077.SGD","IAI","SG9999014880.SGD","LU0158827781.USD","LU2089284900.SGD","BK4112","BK4597","SG9999014898.SGD","LU2764263039.SGD","LU0345774631.USD","LU1633808545.USD","LU0868494617.USD","IE00B19Z9505.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":187,"code":"91000000","status":"200"}]}}